U.S. IPO Weekly Recap: SK Hynix Raises More Than $26 Billion In Its U.S. IPO And Trades Up 13%

IPO activity was light last week with just one IPO priced, alongside a few SPACs. Looking ahead, two larger IPOs are scheduled for the coming week (with some smaller deals potentially added), while research coverage is expected for three companies and one lock-up period will expire—factors that could modestly influence near-term deal and stock sentiment.

Analysis

The main market mechanism here is not fundamentals but supply. A thin IPO tape supports scarcity premiums in recent listings; a fuller calendar plus one lock-up expiry should modestly weaken that support, especially for unprofitable growth names where price discovery is still fragile. The first-order winners are underwriters and bookrunners, but the more durable beneficiaries are secondary-market investors who can redeploy capital away from crowded new issues into higher-quality late-stage growth.

The near-term risk is that even a small increase in deal flow can create a local liquidity drain: allocators often sell lower-conviction IPO exposure to fund new books, which can pressure the Renaissance IPO ETF (IPO) and the First Trust US Equity Opportunities ETF (FPX) before it shows up in broader indices. Over 1-3 months, the bigger question is whether these offerings clear well enough to pull more private-company supply forward; strong aftermarket performance would reverse the bearish technical read, while weak pricing or deferred deals would reinforce it.

Contrarian view: this is likely over-read if the two scheduled deals are modest and well-sponsored. A handful of SPACs is still a far cry from a true issuance wave, so absent a meaningful pickup in size/quality, the signal is more about microstructure than a regime shift. The key falsifier is simple: if the upcoming IPOs price inside range and trade up on volume, the scarcity overhang thesis should be trimmed quickly.

Key Decisions for Investors

• Tactically underweight IPO (Renaissance IPO ETF) versus QQQ for the next 2-4 weeks; thesis only works if the new issue calendar grows and aftermarket performance is weak. Cover if the upcoming IPOs price well and hold gains above issue price for 3-5 sessions.
• Use FPX as a higher-quality version of the same view: short FPX only on strength after pricing week, targeting a modest relative-value drift lower over 1-2 months as capital rotates to new deals. Stop if issuance stays small or if broad growth leadership re-accelerates.
• Do not chase first-day pops in new listings; wait for lock-up windows and secondary selling to pass. This is an execution rule rather than a trade, but it protects against the most common post-IPO drawdown over the next 30-90 days.
• Keep SPAK on watch only, not as an outright position. If SPAC count or size starts to accelerate beyond this week's small sample, then a tactical short could make sense; otherwise the signal is too weak to pay carry.
• If the IPO calendar expands materially next week, consider a short IPO / long QQQ pair trade; the relative-value setup improves if risk appetite is intact but capital is forced to absorb incremental supply.